Q-omics provides the consensus-scored C2orf27A profile across patient tissues and cancer cell-line models. Additionally, C2orf27A RNA expression shows 15,092 significant protein co-abundance associations, with the highest sampling consensus in BRCA.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for C2orf27A — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with C2orf27A in patient tissues and cancer cell lines. In patient samples, C2orf27A shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set. In cancer cell lines, C2orf27A RNA and mutation anchors are most strongly linked to RNA-expression features, especially in NCI60_ALL.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	15,092	BRCA (3899)	view →
Function (mass-spec)	1,438	PDAC (359)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Inducing drug	2	NCI60_ALL (2)	view →